March 2014 FDA Recall Drug by Pharmakon Pharmaceuticals
D-1362-2014 - Superpotent Drug

This Class I drug recall was voluntarily initiated by Pharmakon Pharmaceuticals on March 26, 2014 for the product Drug. The FDA reported the reason for recall as superpotent drug. The product was distributed in IN and the recall is currently terminated.

Recall Number: D-1362-2014

Reason for Recall
Superpotent Drug: Product contains twice the stated amount of midazolam.
Initiated
03-26-2014
Reported
06-18-2014
Quantity
80 syringes

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
67903
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class I - is a situation in which there is a reasonable probability that the use of, or exposure to, a violative product will cause serious adverse health consequences or death.
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Pharmakon Pharmaceuticals
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Telephone
Distribution Pattern About Distribution Pattern
General area of initial distribution.
IN
Termination Date About Termination Date
Date that FDA officially terminated the recall.
07-31-2014
Product Description About Product Description
Full technical description of the product.
Midazolam 0.2 mg/2 mL 0.9% Sodium Chloride syringes, Total dosage: 0.4 mg per 2 mL, Rx Only, Pharmakon Pharmaceuticals, Inc., 14450 Getz Rd, Noblesville, Indiana, NDC 45183-0014-69.

Batch or Lot Expiration Information

Lot# : E1016227C, Exp. 4/21/2014; E0433735C, Exp. 4/20/2014